Form 8-K - Current report:
SEC Accession No. 0001193125-24-219621
Filing Date
2024-09-16
Accepted
2024-09-16 16:21:56
Documents
3
Period of Report
2024-09-16
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d888081d8k.htm 8-K 20842
2 EX-3.1 d888081dex31.htm EX-3.1 29641
3 EX-3.2 d888081dex32.htm EX-3.2 121930
  Complete submission text file 0001193125-24-219621.txt   173574
Mailing Address 12406 HORESHAM STREET CARMEL IN 46032
Business Address 12406 HORESHAM STREET CARMEL IN 46032 3179893100
MBX Biosciences, Inc. (Filer) CIK: 0001776111 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42272 | Film No.: 241301300
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)